Trial Profile
Effects of Tiotropium on Walking Capacity in Patients With COPD.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2011
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 23 Jun 2011 Primary endpoint 'Endurance' has been met, based on results published in the European Respiratory Journal.
- 23 Jun 2011 Results published in the European Respiratory Journal.
- 08 Mar 2011 New trial record